This conference has now taken place
Depressive disorders and epilepsy are two conditions that are very closely related. Not surprisingly, depressive disorders are the most frequent psychiatric comorbidity in patients with epilepsy. The impact of depressive disorders is multidimensional, including an association with a worse response to pharmacologic and surgical treatment of the seizure disorder.
The purpose of this conference is to review in detail the various aspects of the close relationship between these two conditions, starting from an analysis of available neurobiologic data and including both theoretical implications and practical clinical applications.
Watch and listen as Professor Andres M. Kanner, Conference Co-chair, explains the need for a conference on epilepsy and depressive disorders.
- Alan Ettinger, Mineola, USA
- Dale Hesdorffer, Columbia University College of Physicians and Surgeons and Sergievsky Center, USA
- Marco Mula, Amedeo Avogadro University, Italy
- Michael Trimble, Institute of Neurology Queen Square, UK
- Raman Sankar, University of California, USA
- Tallie Z. Baram, University of California, USA
- Frank Gilliam, Geisinger Clinic, USA
- Phillippe Ryvlin, Lyon, France
- Bruce Hermann, University of Wisconsin, USA
- Rochelle Caplan, University of California, USA
- David Dunn, Indiana University, USA
- Curt LaFrance, Brown University, USA
At the end of the conference participants will be able to:
- Recognize the relatively high prevalence of comorbid depressive disorders in patients with epilepsy.
- Recognize potential common pathogenic mechanisms operant in epilepsy and depression.
- Identify structural and functional changes in neuroimaging studies in depressive disorders.
- Describe and discuss the impact of comorbid depressive disorders on cognitive functions in patients with depressive disorders and epilepsy.
- Identify the various clinical manifestations of depressive disorders in children and adults with epilepsy.
- Evaluate treatment options of depressive disorders in patients with epilepsy.
Sessions will cover:
- Epidemiologic perspectives
- Neurobiologic aspects
- Neuropsychological aspects
- Clinical manifestations and implications
Watch a short video in which Professor Kanner outlines the benefits of attending the conference.
Who will attend?
This educational activity will be of great value to Neuroscientists, Epileptologists, Neurologists, Psychiatrists, Nurses, Psychologists, Social Workers, Child Neurologists, Neuropsychologists and other healthcare professionals who treat Epileptic and Depressive Disorders.
The official language of the conference will be English.